Abstract
The currently available AI tools can help in Diabetic retinopathy screening in a cost effective manner, round the clock availability to the internist, and prompt referrals can help control the disease burden.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
